| __timestamp | ADMA Biologics, Inc. | MorphoSys AG |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 9689000 |
| Thursday, January 1, 2015 | 6745968 | 10431000 |
| Friday, January 1, 2016 | 8494742 | 9618000 |
| Sunday, January 1, 2017 | 18092835 | 12348000 |
| Monday, January 1, 2018 | 22502922 | 28310241 |
| Tuesday, January 1, 2019 | 25910757 | 59336147 |
| Wednesday, January 1, 2020 | 35050817 | 159145941 |
| Friday, January 1, 2021 | 42896889 | 199800000 |
| Saturday, January 1, 2022 | 52458024 | 90225000 |
| Sunday, January 1, 2023 | 59020000 | 92538000 |
Unleashing insights
In the competitive world of biotechnology, effective cost management is crucial for sustaining growth and innovation. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent players: ADMA Biologics, Inc. and MorphoSys AG, from 2014 to 2023. Over this period, MorphoSys AG consistently outpaced ADMA Biologics in SG&A spending, peaking in 2021 with expenses nearly doubling those of ADMA. Notably, MorphoSys's SG&A expenses surged by over 1,900% from 2014 to 2021, reflecting strategic investments in expansion and R&D. Meanwhile, ADMA Biologics exhibited a steady increase, with a 1,100% rise, indicating a more conservative growth strategy. These trends highlight the diverse approaches to cost management within the biotech sector, offering valuable insights for investors and industry analysts alike.
Intra-Cellular Therapies, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Halozyme Therapeutics, Inc. or ADMA Biologics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Axsome Therapeutics, Inc. vs ADMA Biologics, Inc.
Operational Costs Compared: SG&A Analysis of TG Therapeutics, Inc. and MorphoSys AG
Who Optimizes SG&A Costs Better? Verona Pharma plc or MorphoSys AG
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of ADMA Biologics, Inc. and Mesoblast Limited
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs MorphoSys AG
Xenon Pharmaceuticals Inc. vs MorphoSys AG: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for MorphoSys AG and Geron Corporation
SG&A Efficiency Analysis: Comparing MorphoSys AG and Galapagos NV
Breaking Down SG&A Expenses: MorphoSys AG vs Novavax, Inc.